# An Follow-Up Study of Liver Cirrhosis

> **NCT03472742** · — · COMPLETED · sponsor: **Rohto Pharmaceutical Co., Ltd.** · enrollment: 19 (actual)

## Conditions studied

- Decompensated Liver Cirrhosis

## Interventions

- **DRUG:** Mesenchymal Stem Cell

## Key facts

- **NCT ID:** NCT03472742
- **Lead sponsor:** Rohto Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2023-10-12
- **Final completion:** 2023-10-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03472742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03472742, "An Follow-Up Study of Liver Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03472742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*